Viewing Study NCT04673357


Ignite Creation Date: 2025-12-24 @ 6:33 PM
Ignite Modification Date: 2025-12-26 @ 6:45 AM
Study NCT ID: NCT04673357
Status: COMPLETED
Last Update Posted: 2025-11-28
First Post: 2020-12-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Janssen Research & Development, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module